The FDA approved a new monthly paliperidone palmitate (Erzofri) extended-release injectable suspension for treating schizophrenia in adults, Luye Pharma announced. An atypical antipsychotic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback